Pfs Investments Inc. Revance Therapeutics, Inc. Transaction History
Pfs Investments Inc.
- $6.12 Billion
- Q2 2023
A detailed history of Pfs Investments Inc. transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Pfs Investments Inc. holds 10,799 shares of RVNC stock, worth $27,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,799
Previous 9,287
16.28%
Holding current value
$27,753
Previous $316,000
13.61%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RVNC
# of Institutions
25Shares Held
10.3MCall Options Held
360KPut Options Held
0-
Black Rock Inc. New York, NY8.57MShares$22 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL423KShares$1.09 Million0.0% of portfolio
-
Rothschild & CO Asset Management Us Inc. New York, NY370KShares$949,9950.1% of portfolio
-
International Biotechnology Trust PLC London, X0289KShares$742,0251.12% of portfolio
-
Credit Suisse Ag Zurich, V8180KShares$462,9800.0% of portfolio
About Revance Therapeutics, Inc.
- Ticker RVNC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,305,696
- Market Cap $212M
- Description
- Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...